Boston Scientific plans to use the IDE trials results to support a regulatory filing of its Seismiq 4CE Coronary catheter with the FDA.
Original Image Link
Source:www.medicaldevice-network.com
Original Image Link
Source:www.medicaldevice-network.com
Posted: 2026-05-19 12:41:00

















